Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 18, 2014 08:00 ET | Source: Bioblast Pharma Ltd.

BioBlast Receives Notice of Allowance From USPTO for Its Novel Fusion Protein-Based Platform for the Treatment of Friedrich's Ataxia

TEL AVIV, Israel, Aug. 18, 2014 (GLOBE NEWSWIRE) -- BioBlast Pharma Ltd, (Nasdaq:ORPN) a clinical-stage biotechnology company committed to developing clinically meaningful therapies for patients with...
July 30, 2014 18:33 ET | Source: Bioblast Pharma Ltd.

Bio Blast Pharma Prices Initial Public Offering of $35,200,000 of Ordinary Shares

TEL AVIV, Israel, July 30, 2014 (GLOBE NEWSWIRE) -- Bio Blast Pharma Ltd. ("BioBlast"), a clinical-stage biotechnology company committed to developing clinically meaningful therapies for patients with...